CY1109029T1 - Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη ονομαζομενη 85p1b3 χρησιμα στην αγωγη και τον εντοπισμο του καρκινου - Google Patents
Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη ονομαζομενη 85p1b3 χρησιμα στην αγωγη και τον εντοπισμο του καρκινουInfo
- Publication number
- CY1109029T1 CY1109029T1 CY20081101252T CY081101252T CY1109029T1 CY 1109029 T1 CY1109029 T1 CY 1109029T1 CY 20081101252 T CY20081101252 T CY 20081101252T CY 081101252 T CY081101252 T CY 081101252T CY 1109029 T1 CY1109029 T1 CY 1109029T1
- Authority
- CY
- Cyprus
- Prior art keywords
- brand
- diagnosis
- useful
- cancer treatment
- corresponding protein
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 1
- 230000000366 juvenile effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Περιγράφονται ένα νέο γονίδιο (ονομαζόμενο 85Ρ1Β3) και η κωδικοποιούμενη από αυτό πρωτεΐνη. Ενώ η 85Ρ1Β3 εμφανίζει επιλεκτική των ιστών έκφραση στους φυσιολογικούς ιστούς ανηλίκου, εκφράζεται ανώμαλα σε πολυάριθμους καρκίνους περιλαμβάνοντες τους παρατιθέμενους στον Πίνακα 1. Κατά συνέπεια, η 85Ρ1Β3 παρέχει ένα διαγνωστικό και/ή θεραπευτικό στόχο για καρκίνους. Το γονίδιο 85Ρ1Β3 ή ένα θραύσμα του, ή η κωδικοποιούμενη από αυτό πρωτεΐνη ή ένα θραύσμα της, μπορούν να χρησιμοποιηθούν για την πρόκληση μίας ανοσολογικής αντιδράσεως.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22843200P | 2000-08-28 | 2000-08-28 | |
EP01968204A EP1313850B1 (en) | 2000-08-28 | 2001-08-28 | Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1109029T1 true CY1109029T1 (el) | 2014-07-02 |
Family
ID=22857145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081101252T CY1109029T1 (el) | 2000-08-28 | 2008-11-04 | Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη ονομαζομενη 85p1b3 χρησιμα στην αγωγη και τον εντοπισμο του καρκινου |
Country Status (11)
Country | Link |
---|---|
US (3) | US7217799B2 (el) |
EP (2) | EP1313850B1 (el) |
AT (1) | ATE403716T1 (el) |
AU (3) | AU8846601A (el) |
CA (2) | CA2705366A1 (el) |
CY (1) | CY1109029T1 (el) |
DE (1) | DE60135232D1 (el) |
DK (1) | DK1313850T3 (el) |
ES (1) | ES2311540T3 (el) |
PT (1) | PT1313850E (el) |
WO (1) | WO2002018578A2 (el) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60135232D1 (de) | 2000-08-28 | 2008-09-18 | Agensys Inc | Nukleinsäure und korrespondierendes protein 85p1b3, nützlich zur behandlung und detektion von krebserkrankungen |
WO2006036922A2 (en) * | 2004-09-27 | 2006-04-06 | Centocor, Inc. | Srage mimetibody, compositions, methods and uses |
RU2011111411A (ru) * | 2008-08-28 | 2012-10-10 | Онкотерапи Сайенс, Инк. (Jp) | Oip5 в качестве гена-мишени для терапии и диагностики рака |
US8449512B2 (en) | 2010-04-09 | 2013-05-28 | Davinci Biomedical Research Products Inc. | Stoma stabilitating device and method |
CN114195861A (zh) * | 2022-01-05 | 2022-03-18 | 许昌学院 | 亲和肽 |
Family Cites Families (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
CA2044593C (en) | 1989-11-03 | 2004-04-20 | Kenneth L. Brigham | Method of in vivo delivery of functioning foreign genes |
US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
DK0463151T3 (da) | 1990-01-12 | 1996-07-01 | Cell Genesys Inc | Frembringelse af xenogene antistoffer |
US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
US5279833A (en) | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
US5204253A (en) | 1990-05-29 | 1993-04-20 | E. I. Du Pont De Nemours And Company | Method and apparatus for introducing biological substances into living cells |
US5723286A (en) | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
ES2264239T3 (es) | 1990-06-27 | 2006-12-16 | Princeton University | Complejo de proteinas p53/p90'. |
SE9002480D0 (sv) | 1990-07-23 | 1990-07-23 | Hans Lilja | Assay of free and complexed prostate-specific antigen |
US5733731A (en) | 1991-10-16 | 1998-03-31 | Affymax Technologies N.V. | Peptide library and screening method |
IL105914A0 (en) | 1992-06-04 | 1993-10-20 | Univ California | Methods and compositions for in vivo gene therapy |
EP1704868A1 (en) | 1992-08-07 | 2006-09-27 | Pharmexa Inc. | HLA binding peptides and their uses |
US5489525A (en) * | 1992-10-08 | 1996-02-06 | The United States Of America As Represented By The Department Of Health And Human Services | Monoclonal antibodies to prostate cells |
BR9406652A (pt) | 1993-03-05 | 1996-09-10 | Cytel Corp | Composição |
US5837501A (en) | 1993-07-09 | 1998-11-17 | Akzo Nobel N.V. | Nucleic acid quantitation by co-amplification of target with multiple internal controls |
US5679647A (en) | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
US5804566A (en) | 1993-08-26 | 1998-09-08 | The Regents Of The University Of California | Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
ATE415173T1 (de) | 1993-09-14 | 2008-12-15 | Pharmexa Inc | Pan dr-bindeproteinen zur erhöhung der immunantwort |
CH686982A5 (fr) | 1993-12-16 | 1996-08-15 | Maurice Stroun | Méthode pour le diagnostic de cancers. |
US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
EP0773952B1 (en) | 1994-07-20 | 2003-11-12 | The General Hospital Corporation | Interaction trap systems for detecting protein interactions |
US5919652A (en) | 1994-11-09 | 1999-07-06 | The Regents Of The University Of California | Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof |
US5736524A (en) | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
US5962428A (en) | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
WO1996032503A1 (en) | 1995-04-11 | 1996-10-17 | The General Hospital Corporation | Reverse two-hybrid systems |
US5922687A (en) | 1995-05-04 | 1999-07-13 | Board Of Trustees Of The Leland Stanford Junior University | Intracellular delivery of nucleic acids using pressure |
CU22559A1 (es) | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
JP2001504799A (ja) | 1996-03-11 | 2001-04-10 | エピミューン インコーポレイテッド | Hla分子への結合アフィニティーが増加したペプチド |
EP0907750B1 (en) | 1996-04-26 | 2002-09-18 | Massachusetts Institute Of Technology | Three-hybrid screening assay |
US6294378B1 (en) | 1996-07-26 | 2001-09-25 | Sloan-Kettering Institute For Cancer Research | Method and reagents for genetic immunization |
US5925523A (en) | 1996-08-23 | 1999-07-20 | President & Fellows Of Harvard College | Intraction trap assay, reagents and uses thereof |
JP2001502537A (ja) | 1996-10-15 | 2001-02-27 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | ヒト前立腺ガンの進行の動物モデル |
US5846722A (en) | 1996-10-16 | 1998-12-08 | Terrapin Technologies, Inc. | System to detect small molecule/peptide interaction |
US5840501A (en) | 1996-10-25 | 1998-11-24 | Bayer Corporation | Determination of cPSA |
JP4215172B2 (ja) | 1996-12-03 | 2009-01-28 | アムジェン フレモント インク. | 複数のV▲下H▼およびV▲下κ▼領域を含むヒトIg遺伝子座を有するトランスジェニック哺乳動物、ならびにそれから産生される抗体 |
US6261791B1 (en) * | 1997-03-10 | 2001-07-17 | The Regents Of The University Of California | Method for diagnosing cancer using specific PSCA antibodies |
AU6891098A (en) | 1997-04-10 | 1998-10-30 | Genetics Institute Inc. | Secreted expressed sequence tags (sests) |
EP1242443A4 (en) * | 1999-12-23 | 2005-06-22 | Nuvelo Inc | NEW NUCLEIC ACIDS AND POLYPEPTIDES |
WO2001055321A2 (en) | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
US20030165843A1 (en) | 2000-07-28 | 2003-09-04 | Avi Shoshan | Oligonucleotide library for detecting RNA transcripts and splice variants that populate a transcriptome |
GB0031021D0 (en) | 2000-07-31 | 2001-01-31 | Aventis Pharma Ltd | Polynucleotides and polypeptides |
DE60135232D1 (de) | 2000-08-28 | 2008-09-18 | Agensys Inc | Nukleinsäure und korrespondierendes protein 85p1b3, nützlich zur behandlung und detektion von krebserkrankungen |
-
2001
- 2001-08-28 DE DE60135232T patent/DE60135232D1/de not_active Expired - Lifetime
- 2001-08-28 DK DK01968204T patent/DK1313850T3/da active
- 2001-08-28 AU AU8846601A patent/AU8846601A/xx active Pending
- 2001-08-28 CA CA2705366A patent/CA2705366A1/en not_active Abandoned
- 2001-08-28 EP EP01968204A patent/EP1313850B1/en not_active Expired - Lifetime
- 2001-08-28 CA CA2420990A patent/CA2420990C/en not_active Expired - Fee Related
- 2001-08-28 WO PCT/US2001/026838 patent/WO2002018578A2/en active IP Right Grant
- 2001-08-28 EP EP08161748A patent/EP2022797A3/en not_active Withdrawn
- 2001-08-28 ES ES01968204T patent/ES2311540T3/es not_active Expired - Lifetime
- 2001-08-28 PT PT01968204T patent/PT1313850E/pt unknown
- 2001-08-28 AU AU2001288466A patent/AU2001288466B2/en not_active Ceased
- 2001-08-28 US US09/942,052 patent/US7217799B2/en not_active Expired - Fee Related
- 2001-08-28 AT AT01968204T patent/ATE403716T1/de active
-
2006
- 2006-07-19 US US11/489,907 patent/US7501502B2/en not_active Expired - Fee Related
-
2007
- 2007-06-27 AU AU2007202977A patent/AU2007202977B2/en not_active Ceased
-
2008
- 2008-11-04 CY CY20081101252T patent/CY1109029T1/el unknown
-
2009
- 2009-01-23 US US12/359,203 patent/US8173381B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2705366A1 (en) | 2002-03-07 |
AU2007202977A1 (en) | 2007-07-19 |
AU2001288466B2 (en) | 2007-03-29 |
CA2420990C (en) | 2010-08-17 |
DK1313850T3 (da) | 2008-12-01 |
AU8846601A (en) | 2002-03-13 |
AU2007202977B2 (en) | 2010-06-03 |
EP2022797A3 (en) | 2011-11-09 |
US20090203016A1 (en) | 2009-08-13 |
EP2022797A2 (en) | 2009-02-11 |
US20030170626A1 (en) | 2003-09-11 |
US8173381B2 (en) | 2012-05-08 |
CA2420990A1 (en) | 2002-03-07 |
PT1313850E (pt) | 2008-11-18 |
US7501502B2 (en) | 2009-03-10 |
AU2001288466B9 (en) | 2002-03-13 |
US7217799B2 (en) | 2007-05-15 |
DE60135232D1 (de) | 2008-09-18 |
WO2002018578A2 (en) | 2002-03-07 |
US20070036762A1 (en) | 2007-02-15 |
ES2311540T3 (es) | 2009-02-16 |
EP1313850B1 (en) | 2008-08-06 |
WO2002018578A3 (en) | 2002-10-03 |
ATE403716T1 (de) | 2008-08-15 |
EP1313850A2 (en) | 2003-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1110256T1 (el) | Διαμεμβρανικο αντιγονο λεκτινης τυπου c εκφραζομενο σε καρκινο στον προστατη ανθρωπου και χρησεις αυτου | |
HK1110876A1 (en) | Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers | |
CY1108765T1 (el) | ΑΓΩΓΗ ME ΑΝΤΙΣΩΜΑΤΑ ANTI-ErbB2 | |
CY1109125T1 (el) | Θεραπευτικα και διαγνωστικα anti-hsp 70 αντισωματα | |
CY1113247T1 (el) | Νουκλεϊνικα οξεα με τιτλο 273ρ4β7 και η χρηση τους στην ανιχνευση καρκινου | |
NO20014415L (no) | Medisinske preparater til behandling av <alfa>-galaktosidase- A-defisiens | |
TR200103560T2 (tr) | Göğüs kanserinin teşhis ve tedavisi için bileşimler ve bunların kullanımı | |
MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
MXPA02000192A (es) | Composiciones y metodos para la terapia y diagnostico de cancer de pulmon. | |
MY155218A (en) | Small molecules useful in the treatment of inflammatory disease | |
CY1109029T1 (el) | Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη ονομαζομενη 85p1b3 χρησιμα στην αγωγη και τον εντοπισμο του καρκινου | |
BR0306715A (pt) | Métodos para diagnóstico e tratamento de tumores | |
DK0786004T3 (da) | Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase | |
ES2179204T3 (es) | Hidrazinas 2-aminocarbonil-1,2-bis(metilsulfonil)-1-sustituidas antitumorales. | |
CY1111522T1 (el) | 84p2a9: ειδικη σε προστατη και ορχεις πρωτεϊνη που εκφραζεται σε υψηλο βαθμο στον προστατικο καρκινο | |
ATE406178T1 (de) | Verhinderung von immunreaktivität durch verarmung oder inhibition von antigen-präsentierenden zellen | |
CY1106363T1 (el) | Χρηση του ενepγοποιημενου παραγοντα πηξης vii για την αγωγη των επαγομενων απο θρομβολυτικη θepαπεια μειζονων αιμορραγιων | |
EP1351967A4 (en) | COMPOSITIONS AND METHODS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER | |
CY1113516T1 (el) | Νουκλεϊκο οξυ και αντιστοιχη πρωτεϊνη με ονομασια 158p1d7 χρησιμα στην αγωγη και ανιχνευση καρκινου ουροδοχου κυστης και αλλων καρκινων | |
NO962248L (no) | Joderte bifenylderivater og deres diagnostiske anvendelse | |
DE3765916D1 (de) | Sonde zur einfuehrung in den verdauungs- oder ausscheidungstrakt des menschlichen oder tierischen koerpers, insbesondere lithotriptor-sonde. | |
AU2177502A (en) | Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof | |
AU2003247704A1 (en) | Methods and compositions for diagnosing hepatocellular carcinoma | |
NO20005321L (no) | Vertskodet protein uttrykt i Mareks sykdoms (MDV) infiserte celler og antistoffer til dette | |
CY1113332T1 (el) | Νουκλεϊκα οξεα και αντιστοιχες πρωτεϊνες με ονομασια 191p4d12(b) χρησιμα στην αγωγη και ανιχνευση καρκινου |